LTI leverages NIH validated and funded programs to develop first in class therapies for niche indications in lung injury and disease.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free